胰腺小岛器官和芯片上的器官用于1型糖尿病
Mahira Mehanović1, Mélanie Lopes1, Sophia Coffy1
1Univ. Grenoble Alpes, CEA, Inserm, IRIG, UA13 BGE, Biomics, Grenoble, France.
概括
先进的小岛器官为研究1型糖尿病 (T1D) 提供了有前途的体外模型. 这些模型模仿胰腺小岛,帮助研究T1D病原和再生疗法.
科学领域:
- 内分泌学 在内分泌学.
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 1型糖尿病 (T1D) 是一种复杂的代谢疾病,涉及胰腺小岛功能障碍.
- 目前的T1D研究重点是胰岛素恢复和葡萄糖平衡,干细胞疗法显示出希望.
- 开发精确的体外模型对于理解小岛发育和糖尿病病理生理学至关重要.
研究的目的:
- 为1型糖尿病 (T1D) 研究提供先进的岛屿有机体模型的洞察力.
- 讨论这些有机体模型的生成,特性,应用和挑战.
- 探索组织工程策略,以回顾胰腺利基和小岛发展.
主要方法:
- 对岛屿有机体生成的最先进组织工程策略的审查.
- 对产生胰岛素的细胞 (原始细胞,细胞系,转基因,干细胞) 的各种细胞来源的探索.
- 讨论结合细胞外矩阵,支架和血管/免疫调节方法来模仿小岛微环境.
主要成果:
- 有机器人提供了与生理相关的3D模型,比传统模型更准确地回顾细胞相互作用和反应.
- 与小岛有机体集成的芯片器官技术显示出疾病建模和药物查的潜力.
- 结合微流体的小岛器官被认为是T1D研究的一个有前途的工具.
结论:
- 先进的小岛类器官模型正在为糖尿病研究带来革命性的3D细胞培养.
- 这些模型,特别是与微流体学相结合时,为了解T1D病原体提供了强大的平台.
- 岛屿有机体具有开发1型糖尿病创新再生疗法的巨大潜力.
相关概念视频
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...


